Closed · RFA-CK-20-002 · CFDA 93.084 · Discretionary
Detection and Characterization of Emerging Vector-Borne and Zoonotic Pathogens in Indonesia
Federal grant opportunity posted by Centers for Disease Control and Prevention - ERA, cataloged on Grants.gov.
- $300K-$1M
- Award range
- Closed
- Status
- January 14, 2020
- Close date
- 1
- Expected awards
The verdict
Detection and Characterization of Emerging Vector-Borne and Zoonotic Pathogens in Indonesia is a closed discretionary listing from Centers for Disease Control and Prevention - ERA that offered $300,000 -- $1,000,000 across 1 expected award. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 639 other opportunities from Centers for Disease Control and Prevention - ERA.
- $300K-$1M
- award range
- Closed
- application status
- 1
- expected award
- 93.084
- CFDA program
Archived opportunity record
Detection and Characterization of Emerging Ve… is closed (last close January 14, 2020). Check the agency catalog for replacement NOFOs. Centers for Disease Control and Prevention - ERA still indexes 639 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed January 14, 2020
Est. Total Funding
$5,000,000
Expected Awards
1
Instrument
Cooperative Agreement
Description
The purpose of this Notice of Funding Opportunity (NOFO) is to support research to enable rapid and accurate identification of emerging vector-borne and zoonotic threats in Indonesia by building upon the scientific and laboratory infrastructure established under two previously awarded NOFOs. Indonesia is a recognized “hotspot” for emerging pathogens. It is the world’s fourth largest population, spread among nearly 1000 inhabited islands stretching 3,400 miles along the equator, making opportunities for an emerging pathogen to become epidemic in the absence of a reliable detection system high. The arthropod-borne viruses (arboviruses) and Rickettsia (typhus and spotted fevers) are of particular concern because of the ease with which vectors can transfer these viruses between wildlife, humans and livestock. Remarkably, little is known about these diseases in Indonesia or their potential for movement within and from the country. For example, only two of 11 pathogenic arboviruses known to be found in neighboring Australia have been identified in Indonesia. Although Indonesia is known historically to be endemic for murine typhus and scrub typhus, they are almost never diagnosed. CDC began a highly successful effort to build Indonesian capacity to identify emerging vector-borne diseases in 2011. This effort helped to (1) build and support a state-of-the-art molecular diagnostic laboratory at Jakarta; (2) conduct countrywide training in virological techniques and biosafety; and (3) pilot a large-scale acute febrile illness (AFI) surveillance network. During the previous cooperative agreement (RFA-CK-15-001), Indonesian and CDC partners identified the first West Nile and Zika virus cases in Indonesia, conducted the first Zika seroprevalence study, and identified Rickettsia felis for the first time as a cause of fatal neurological disease. Indonesia is a leader of the Global Health Security Agenda and the CDC mission supports Indonesia’s efforts to fulfill its Joint External Evaluation (JEE) goals; especially strengthening the national laboratory system and improving the ability of real-time surveillance in detecting emerging pathogens (WHO/OHE/2016.4, Indonesia JEE, November 2017).
Catch-all / unrestricted eligibility mark · RFA-CK-20-002
Grants.gov marks Detection and Characterization of Emerging Ve… with a catch-all / unrestricted eligibility code (Others (see official listing text)). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity code maps to Health (HL). This eligibility-code string dominates the Centers for Disease Control and Prevention - ERA book (299 peers, 47% of 640).
- Code 25
- Others (see official listing text)
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
Amy Yang vdz9@cdc.gov
More from Centers for Disease Control and Prevention - ERA
US Travelers Health Research, Surveillance, Communication, and Outreach Network
Emerging Infections Network - Research for Preventing, Detecting, and Managing Travel-associated Infectious Diseases
Occupational Safety and Health Training Project Grants (T03)
Occupational Safety and Health Education and Research Centers (T42)
RFA-PS-18-000
What to do next
Detection and Characterization of Emerging Ve… is closed; use the parent program and agency catalog for the next funding cycle.
- Browse open federal opportunities in the same category when this listing is closed. Open opportunities
- Look up CFDA 93.084 across all indexed listings before you commit to this opportunity alone. Eligibility finder
- Compare award ranges across federal categories before you pick a single CFDA. All categories
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |